Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...
In this week’s edition of InnovationRx, we look at HHS nominee Robert F. Kennedy Jr.’s first Senate confirmation hearing, the ...
Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee. He appears before the ...
President Donald Trump signed the bipartisan Laken Riley Act into law as his administration’s first piece of legislation.
Zacks.com on MSN21h
Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on UpdatesIt was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...
These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee and will be held Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback